|
Symbol
|
OCJRCH | KAJDEU | RMBE7V | RSDACV | OVCRCH | Z09YJZ | ABVHSQ | PBURCH | RMA3QV | PEIRCH | Z0ARNZ | Z0ATYZ | Z0ATQZ | Z0AUCZ | RMBVBV | ADOJTQ | LZJRCH | LZQRCH | QXPRCH | RMAKZV |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Worst of Callable Reverse Convertible | GOAL | Multi Vonti | Reverse Convertible | Worst of Callable Reverse Convertible | Autocallable Reverse Convertible Defensive worst | Multi Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Autocallable Reverse Convertible Defensive worst | Autocallable Reverse Convertible Defensive worst | Autocallable Reverse Convertible Defensive worst | ZKB Reverse Convertible on worst of Last Look | Multi Vonti | Multi Reverse Convertible | Worst of Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti |
|
Sous-jacent
|
Kühne & Nagel Intl. AG / Lonza Group N / Sandoz Group AG | Julius Baer Group / Sandoz Group AG / Sika AG | Alcon / Sandoz Group AG | Sandoz Group AG | Novartis AG / Sandoz Group AG / Straumann Hldg. AG | Galderma Group AG / Sandoz Group AG / VAT Group | Baloise N / Sandoz Group AG / Sika AG / Straumann Hldg. AG | Alcon / Lonza Group N / Sandoz Group AG | Alcon / Lonza Group N / Novartis AG / Roche AG / Sandoz Group AG | Lonza Group N / Novartis AG / Roche AG / Sandoz | Holcim/Amrize Basket / Lonza Group N / Sandoz Group AG | Alcon / Novartis AG / Sandoz Group AG / Straumann Hldg. AG | Galderma Group AG / Sandoz Group AG / SIG Combibloc / VAT Group | Sandoz Group AG / Swissquote Group Hldg. S.A. / Ypsomed Hldg. AG | Baloise N / Compagnie Financière Richemont SA / Sandoz Group AG | ABB / Compagnie Financière Richemont SA / Sandoz Group AG | Alcon / Lonza Group N / Novartis AG / Sandoz Group AG / Siegfried Hldg. AG | Givaudan / Novartis AG / Sandoz Group AG | Alcon / Lonza Group N / Sandoz Group AG | Lonza Group N / Sandoz Group AG / Siegfried Hldg. AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
08.04.2026 | 06.07.2026 | 13.07.2026 | 30.12.2025 | 09.06.2026 | 02.03.2026 | 07.10.2026 | 21.07.2026 | 09.11.2026 | 11.11.2026 | 25.08.2026 | 05.03.2027 | 07.09.2026 | 10.03.2026 | 13.03.2026 | 23.07.2026 | 24.07.2026 | 07.08.2029 | 25.08.2027 | 01.09.2028 |
| Ratio | - | - | - | 0,006458 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
192,6425 | 171,68 | 64,50 | 32,29 | 27,975 | 29,2061 | 22,8865 | 26,509 | 56,14 | 384,30 | 76,4918 | 66,1674 | 28,6272 | 35,676 | 31,104 | 124,334 | 67,425 | 2 627,25 | 35,955 | 428,70 |
| rendement max. p.a. | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Demande | - | 92,35 | 96,10 | 100,40 | - | - | - | - | 97,70 | 99,43 | - | - | - | 109,68 | 98,20 | 101,74 | - | - | - | 95,10 |
| Offre | - | 93,35 | 96,90 | 101,00 | - | - | - | - | 98,50 | 100,23 | - | - | - | 110,43 | 99,00 | 102,56 | - | - | - | 96,10 |